Health Catalyst (HCAT) Tops Q2 EPS by 7c, Revenues Beat; Offers 3Q Revenue Guidance Above Consensus, FY20 Revenue Mid-Point Guidance Above Consensus

Health Catalyst (NASDAQ: HCAT) reported Q2 EPS of ($0.15), $0.07 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $43.26 million versus the consensus estimate of $42.14 million.

“First, let me express our ongoing gratitude to all the heroic national health systems and their front-line workers. We are both grateful and honored that our health system customers have continued to trust us so meaningfully to support them in this time of great need,” said Dan Burton, CEO of Health Catalyst. “From a financial perspective, I am very pleased with our performance in the second quarter across all areas of our business, including outperforming the mid-point of our guidance for both total revenue and Adjusted EBITDA. In addition to this financial and operational execution, I was particularly pleased to see that our team member overall satisfaction score, as measured by Gallup, ranked in the 99th percentile once again. This past period's score, the second highest in the company's history, was particularly encouraging as we adapted to a remote-only culture.”

Mr. Burton continued: “We are hosting our seventh annual Healthcare Analytics Summit in September. While the format will be virtual this year, we continue to believe this conference represents a meaningful opportunity for Health Catalyst to continue to provide thought leadership within the healthcare data and analytics ecosystem, while carefully listening to our customers and prospects as we further cultivate and deepen those relationships. The theme of this year's conference will be healthcare analytics in the ‘new normal’, and we are fortunate to feature many of the leading voices in the country as our keynote speakers.”

GUIDANCE:

Health Catalyst sees Q3 2020 revenue of $43-46 million, versus the consensus of $42.15 million.

Health Catalyst sees FY2020 revenue of $177.2-181.2 million, versus the consensus of $178.79 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Central Securities (CET) Releases Report to Stockholders
• Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short